CoverageForm 410-K10-Q8-K13D13G13F

Cross John Harry III

CIK 0001806763
Chief Financial Officer

Filings

4

Latest Mar 11, 2025

Issuers covered

2

Showing

4 of 4

Page 1

Track record

Realized signed returns on open-market buys and sales

No scored trades yet for Cross John Harry III. Track record appears once open-market purchases or sales reach the +30 day horizon.

Issuers

Companies where Cross John Harry III has filed

TickerIssuerFilingsLast filed
SONNSonnet Biotherapeutics Holdings, Inc.3Dec 5, 2024
SNTISenti Biosciences, Inc.1Mar 11, 2025

All filings

4 Form 4 / 4-A filings, newest first

Sign in to download
Filed Top transactionSharesPriceValue